Advancing risk assessment of engineered nanomaterials: Application of computational approaches

Advanced Drug Delivery Reviews

Volumn 64, Issue 15, 2012, Pages 1663-1693

  Gajewicz, Agnieszka ^a   Rasulev, Bakhtiyor ^b   Dinadayalane, Tandabany C ^b   Urbaszek, Piotr ^a   Puzyn, Tomasz ^a   Leszczynska, Danuta ^c   Leszczynski, Jerzy ^b  

^a UNIVERSITY OF GDA SK   (Poland)

^b JACKSON STATE UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

Nano QSAR; Nanodescriptors; Nanomaterials; Nanoparticles; Quantum chemical methods; Toxicity

Indexed keywords

COMPUTATIONAL APPROACH; COSMETIC INDUSTRY; ECOTOXICITY; ENGINEERED NANOMATERIALS; EXPERIMENTAL PROTOCOLS; INTRINSIC PROPERTY; LIVING ORGANISMS; MODERN MEDICINE; NANO-QSAR; NANODESCRIPTORS; NOVEL MATERIALS; PHOTOVOLTAIC; QUANTUM-CHEMICAL METHODS;

BIOLOGY; COMPUTATIONAL METHODS; ELECTRONICS INDUSTRY; MEDICINE; NANOPARTICLES; NANOSTRUCTURED MATERIALS; NANOTECHNOLOGY; QUANTUM CHEMISTRY; RISK ASSESSMENT;

TOXICITY;

CARBON NANOPARTICLE; METAL OXIDE NANOPARTICLE; MULTI WALLED NANOTUBE; NANOMATERIAL; NANOPARTICLE; SINGLE WALLED NANOTUBE; UNCLASSIFIED DRUG;

ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; EYE IRRITATION; HAZARD ASSESSMENT; HEALTH HAZARD; HUMAN; MATHEMATICAL COMPUTING; MOLECULAR IMAGING; MOLECULAR MODEL; NANOANALYSIS; NANOFABRICATION; NANOMEDICINE; NANOTECHNOLOGY; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROCESS DEVELOPMENT; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REACTION TIME; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCANNING ELECTRON MICROSCOPY; SENSITIVITY ANALYSIS; SKIN IRRITATION; SKIN SENSITIZATION; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ENVIRONMENTAL EXPOSURE; HUMANS; METAL NANOPARTICLES; MODELS, MOLECULAR; NANOPARTICLES; NANOSTRUCTURES; NANOTECHNOLOGY; NANOTUBES, CARBON; PARTICLE SIZE; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RISK ASSESSMENT;

EID: 84869159142     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2012.05.014     Document Type: Review

References (296)

1. Linkov I., Steevens J., Adlakha-Hutcheon G., Bennett E., Chappell M., Colvin V., Davis J.M., Davis T., Elder A., Hansen S., Hakkinen P.B., Hussain S.M., Karkan D., Korenstein R., Lynch I., Metcalfe C., Ramadan A.B., Satterstrom F.K. Emerging methods and tools for environmental risk assessment, decision-making, and policy for nanomaterials: summary of NATO Advanced Research Workshop. J. Nanopart. Res. 2009, 11:513-527.
2. Puzyn T., Gajewicz A., Leszczynska D., Leszczynski J. Nanomaterials - the next great challenge for QSAR modelers. Recent Advances in QSAR Studies: Methods and Applications 2010, M.T. Springer, London, New York. T. Puzyn, J. Leszczynski, M. Cronin (Eds.).
3. Agasti S.S., Rana S., Park M.H., Kim C.K., You C.C., Rotello V.M. Nanoparticles for detection and diagnosis. Adv. Drug Deliv. Rev. 2010, 62:316-328.
4. Das A., Mukherjee P., Singla S.K., Guturu P., Frost M.C., Mukhopadhyay D., Shah V.H., Patra C.R. Fabrication and characterization of an inorganic gold and silica nanoparticle mediated drug delivery system for nitric oxide. Nanotechnology 2010, 21.
5. Mukherjee P. Targeted delivery using inorganic nanosystem. Preface. Adv. Drug Deliv. Rev. 2010, 62:283.
6. Cormode D.P., Jarzyna P.A., Mulder W.J.M., Fayad Z.A. Modified natural nanoparticles as contrast agents for medical imaging. Adv. Drug Deliv. Rev. 2010, 62:329-338.
7. Artiles M.S., Rout C.S., Fisher T.S. Graphene-based hybrid materials and devices for biosensing. Adv. Drug Deliv. Rev. 2011, 63:1352-1360.
8. Venkataraman S., Hedrick J.L., Ong Z.Y., Yang C., Ee P.L., Hammond P.T., Yang Y.Y. The effects of polymeric nanostructure shape on drug delivery. Adv. Drug Deliv. Rev. 2011, 63:1228-1246.
9. Gleiche M., Hoffschulz H., Lenhert S. Nanotechnology in consumer products. Nanoforum Report 2006, E.N. Gateway (Ed.).
10. O'Brien N., Cummins E. Recent developments in nanotechnology and risk assessment strategies for addressing public and environmental health concerns. Hum. Ecol. Risk Assess. 2008, 14:568-592.
11. Analysis of the Nanotechnology Consumer Inventory of August 25, 2009 2009, Available at: http://www.nanotechproject.org/inventories/consumer/, Woodrow Wilson International Centre for Scholars.
12. Nanomaterials State of the Market Q3 2008: Stealth Success, Broad Impact 2008, Lux Research, New York.
13. Li N., Sioutas C., Cho A., Schmitz D., Misra C., Sempf J., Wang M., Oberley T., Froines J., Nel A. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ. Health Perspect. 2003, 111:455-460.
14. Xia T., Kovochich M., Brant J., Hotze M., Sempf J., Oberley T., Sioutas C., Yeh J.I., Wiesner M.R., Nel A.E. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 2006, 6:1794-1807.
15. Penn A., Murphy G., Barker S., Henk W., Penn L. Combustion-derived ultrafine particles transport organic toxicants to target respiratory cells. Environ. Health Perspect. 2005, 113:956-963.
16. Tian F., Cui D., Schwarz H., Estrada G.G., Kobayashi H. Cytotoxicity of single-wall carbon nanotubes on human fibroblasts. Toxicol. In Vitro 2006, 20:1202-1212.
17. Chen M., von Mikecz A. Formation of nucleoplasmic protein aggregates impairs nuclear function in response to SiO2 nanoparticles. Exp. Cell Res. 2005, 305:51-62.
18. Yokoyama A., Sato Y., Nodasaka Y., Yamamoto S., Kawasaki T., Shindoh M., Kohgo T., Akasaka T., Uo M., Watari F., Tohji K. Biological behavior of hat-stacked carbon nanofibers in the subcutaneous tissue in rats. Nano Lett. 2005, 5:157-161.
19. Nel A. Air pollution-related illness: effects of particles. Science 2005, 308:804-806.
20. Nel A., Xia T., Madler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311:622-627.
21. Oberdörster G., Oberdörster E., Oberdörster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005, 113:823-839.
22. Panessa-Warren B.J., Warren J.B., Maye M.M., van der Lelie D., Gang O., Wong S.S., Ghebrehiwet B., Tortora G.T., Misewich J.A. Human epithelial cell processing of carbon and gold nanoparticles. Int. J. Nanotechnol. 2008, 5:55-91.
23. Panessa-Warren B.J., Warren J.B., Wong S.S., Misewich J.A. Biological cellular response to carbon nanoparticle toxicity. J. Phys. Condens. Matter 2006, 18:S2185-S2201.
24. Cui D., Tian F., Ozkan C.S., Wang M., Gao H. Effect of single wall carbon nanotubes on human HEK293 cells. Toxicol. Lett. 2005, 155:73-85.
25. Auffan M., Decome L., Rose J., Orsiere T., De Meo M., Briois V., Chaneac C., Olivi L., Berge-Lefranc J.L., Botta A., Wiesner M.R., Bottero J.Y. In vitro interactions between DMSA-coated maghemite nanoparticles and human fibroblasts: a physicochemical and cyto-genotoxical study. Environ. Sci. Technol. 2006, 40:4367-4373.
26. Thill A., Zeyons O., Spalla O., Chauvat F., Rose J., Auffan M., Flank A.M. Cytotoxicity of CeO2 nanoparticles for Escherichia coli. Physico-chemical insight of the cytotoxicity mechanism. Environ. Sci. Technol. 2006, 40:6151-6156.
27. Wiesner M.R., Lowry G.V., Alvarez P., Dionysiou D., Biswas P. Assessing the risks of manufactured nanomaterials. Environ. Sci. Technol. 2006, 40:4336-4345.
28. Nirmala R., Park H.-M., Kalpana D., Kang H.-S., Navamathavan R., Lee Y.-S., Kim H.Y. Bactericidal activity and in vitro cytotoxicity assessment of hydroxyapatite containing gold nanoparticles. J. Biomed. Nanotechnol. 2011, 7:342-350.
29. Asare N., Instanes C., Sandberg W.J., Refsnes M., Schwarze P., Kruszewski M., Brunborg G. Cytotoxic and genotoxic effects of silver nanoparticles in testicular cells. Toxicology 2012, 291:65-72.
30. Long T.C., Saleh N., Tilton R.D., Lowry G.V., Veronesi B. Titanium dioxide (P25) produces reactive oxygen species in immortalized brain microglia (BV2): implications for nanoparticle neurotoxicity. Environ. Sci. Technol. 2006, 40:4346-4352.
31. Wu J., Wang C., Sun J., Xue Y. Neurotoxicity of silica nanoparticles: brain localization and dopaminergic neurons damage pathways. ACS Nano 2011, 5:4476-4489.
32. Win-Shwe T.-T., Fujimaki H. Nanoparticles and neurotoxicity. Int. J. Mol. Sci. 2011, 12:6267-6280.
33. Kumari M., Khan S.S., Pakrashi S., Mukherjee A., Chandrasekaran N. Cytogenetic and genotoxic effects of zinc oxide nanoparticles on root cells of Allium cepa. J. Hazard. Mater. 2011, 190:613-621.
34. Sharma V., Singh S.K., Anderson D., Tobin D.J., Dhawan A. Zinc oxide nanoparticle induced genotoxicity in primary human epidermal keratinocytes. J. Nanosci. Nanotechnol. 2011, 11:3782-3788.
35. Colvin V.L. The potential environmental impact of engineered nanomaterials. Nat. Biotechnol. 2003, 21:1166-1170.
36. Ellegaard-Jensen L., Jensen K.A., Johansen A. Nano-silver induces dose-response effects on the nematode Caenorhabditis elegans. Ecotoxicol. Environ. Saf. 2012, 80:216-223.
37. Yamakoshi Y., Umezawa N., Ryu A., Arakane K., Miyata N., Goda Y., Masumizu T., Nagano T. Active oxygen species generated from photoexcited fullerene (C60) as potential medicines: O2-* versus 1O2. J. Am. Chem. Soc. 2003, 125:12803-12809.
38. Tran N., Mir A., Mallik D., Sinha A., Nayar S., Webster T.J. Bactericidal effect of iron oxide nanoparticles on Staphylococcus aureus. Int. J. Nanomed. 2010, 2010:277-283.
39. Magrez A., Kasas S., Salicio V., Pasquier N., Seo J.W., Celio M., Catsicas S., Schwaller B., Forro L. Cellular toxicity of carbon-based nanomaterials. Nano Lett. 2006, 6:1121-1125.
40. Sayes C.M., Fortner J.D., Guo W., Lyon D., Boyd A.M., Ausman K.D., Tao Y.J., Sitharaman B., Wilson L.J., Hughes J.B., West J.L., Colvin V.L. The differential cytotoxicity of water-soluble fullerenes. Nano Lett. 2004, 4:1881-1887.
41. Gordon T., Chen L.C., Fine J.M., Schlesinger R.B., Su W.Y., Kimmel T.A., Amdur M.O. Pulmonary effects of inhaled zinc oxide in human subjects, guinea pigs, rats, and rabbits. Am. Ind. Hyg. Assoc. J. 1992, 53:503-509.
42. Rehn B., Seiler F., Rehn S., Bruch J., Maier M. Investigations on the inflammatory and genotoxic lung effects of two types of titanium dioxide: untreated and surface treated. Toxicol. Appl. Pharmacol. 2003, 189:84-95.
43. Chen Y., Chen J., Dong J., Jin Y. Comparing study of the effect of nanosized silicon dioxide and microsized silicon dioxide on fibrogenesis in rats. Toxicol. Ind. Health 2004, 20:21-27.
44. Parashar U.K., Kumar V., Bera T., Saxena P.S., Nath G., Srivastava S.K., Giri R., Srivastava A. Study of mechanism of enhanced antibacterial activity by green synthesis of silver nanoparticles. Nanotechnology 2011, 22:415104.
45. Donaldson K., Tran L., Jimenez L.A., Duffin R., Newby D.E., Mills N., MacNee W., Stone V. Combustion-derived nanoparticles: a review of their toxicology following inhalation exposure. Part. Fibre Toxicol. 2005, 2:10.
46. Borm P.J., Robbins D., Haubold S., Kuhlbusch T., Fissan H., Donaldson K., Schins R., Stone V., Kreyling W., Lademann J., Krutmann J., Warheit D., Oberdörster E. The potential risks of nanomaterials: a review carried out for ECETOC. Part. Fibre Toxicol. 2006, 3:11.
47. Savolainena K., Aleniusa H., Norppaa H., Pylkkänena L., Tuomia T., Kasper G. Risk assessment of engineered nanomaterials and nanotechnologies-a review. Toxicology 2010, 269:92-104.
48. Yokel R.A., MacPhail R.C. Engineered nanomaterials: exposures, hazards, and risk prevention. J. Occup. Med. Toxicol. 2011, 6.
49. Dreher K.L. Health and environmental impact of nanotechnology: toxicological assessment of manufactured nanoparticles. Toxicol. Sci. 2004, 77:3-5.
50. Oberdörster G. Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles. Inhal. Toxicol. Suppl. 1996, 73-89.
51. Borm P.J. Particle toxicology: from coal mining to nanotechnology. Inhal. Toxicol. 2002, 14:311-324.
52. Donaldson K., Stone V. Current hypotheses on the mechanisms of toxicity of ultrafine particles. Ann. Ist Super. Sanita. 2003, 39:405-410.
53. Kreyling W.G., Semmler M., Moller W. Dosimetry and toxicology of ultrafine particles. J. Aerosol Med. 2004, 17:140-152.
54. Oberdörster G., Maynard A., Donaldson K., Castranova V., Fitzpatrick J., Ausman K., Carter J., Karn B., Kreyling W., Lai D., Olin S., Monteiro-Riviere N., Warheit D., Yang H. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part. Fibre Toxicol. 2005, 2:8.
55. Aitken R.J., Creely K.S., Tran C.L. Nanoparticles: An Occupational Hygiene Review. Research Report 2004, 274. Institute of Occupational Medicine.
56. Maynard A.D., Aitken R.J., Butz T., Colvin V., Donaldson K., Oberdoroster G., Philbert M.A., Ryan J., Seaton A., Stone V., Tinkle S.S., Tran L., Walker N.J., Warheit D.B. Safe handling of nanotechnology. Nature 2006, 444:267-269.
57. Worth A.P. The role of QSAR methodology in the regulatory assessment of chemicals. Recent Advances in QSAR Studies: Methods and Applications 2010, Springer. T. Puzyn, J. Leszczynski, M.T.D. Cronin (Eds.).
58. OECD, important issues on risk assessment of manufactured nanomaterials. Series on the Safety of Manufactured Nanomaterials No. 33, Organisation for Economic Co-operation and Development, Paris, France 2012.
59. Majestic B.J., Erdakos G.B., Lewandowski M., Oliver K.D., Willis R.D., Kleindienst T.E., Bhave P.V. A review of selected engineered nanoparticles in the atmosphere: sources, transformations, and techniques for sampling and analysis. Int. J. Occup. Environ. Health 2010, 16:488-507.
60. Scown T.M., van Aerle R., Tyler C.R. Review: do engineered nanoparticles pose a significant threat to the aquatic environment?. Crit. Rev. Toxicol. 2010, 40:653-670.
61. Green C.J., Ndegwa S. Nanotechnology: A Review of Exposure, Health Risks and Recent Regulatory Developments 2011, National Collaborating Centre for Environmental Health.
62. OECD Guidance manual for the testing of manufactured nanomaterials: OECD's sponsorship programme; first revision. ENV/JM/MONO(2009)20/REV 2010, 92. OECD. OECD (Ed.).
63. OECD Guidance Document on the Validation of (Quantitative) Structure-Activity Relationship [(Q)SAR] Models. ENV/JM/MONO(2007)2, Organisation for Economic Co-operation and Development 2007, 154. OECD (Ed.).
64. Compendium of Projects in the European NanoSafety Cluster 2011, Institute for Work and Health, Lausanne, Switzerland. M. Riediker, G. Katalagarianakis (Eds.).
65. Paur H.R., Cassee F.R., Teeguarden J., Fissan H., Diabate S., Aufderheide M., Kreyling W.G., Hänninen O., Kasper G., Riediker M., Rothen-Rutishauser B., Schmid O. In-vitro cell exposure studies for the assessment of nanoparticle toxicity in the lung-a dialog between aerosol science and biology. J. Aerosol Sci. 2011, 42:668-692.
66. Kagan V.E., Shi J., Feng W., Shvedova A.A., Fadeel B. Fantastic voyage and opportunities of engineered nanomaterials: what are the potential risks of occupational exposures?. J. Occup. Environ. Med. 2010, 52:943-946.
67. Dinadayalane T.C., Leszczynski J. Unique diversity of carbon-carbon bonds: structures and properties of fullerenes, carbon nanotubes and graphene. Struct. Chem. 2010, 21:1155-1169.
68. Dinadayalane T.C., Leszczynski J. Fundamental structural, electronic and chemical properties of carbon nanostructures: graphene, fullerenes, carbon nanotubes and their derivatives. Handbook of Computational Chemistry 2012, 793-867. Springer, Heidelberg. J. Leszczynski (Ed.).
69. Wu Y.T., Siegel J.S. Aromatic molecular-bowl hydrocarbons: synthetic derivatives, their structures, and physical properties. Chem. Rev. 2006, 106:4843-4867.
70. Allen M.J., Tung V.C., Kaner R.B. Honeycomb carbon: a review of graphene. Chem. Rev. 2010, 110:132-145.
71. Baughman R.H., Zakhidov A.A., de Heer W.A. Carbon nanotubes-the route toward applications. Science 2002, 297:787-792.
72. Uo M., Akasaka T., Watari F., Sato Y., Tohji K. Toxicity evaluations of various carbon nanomaterials. Dent. Mater. J. 2011, 30:245-263.
73. Sanchez V.C., Jachak A., Hurt R.H., Kane A.B. Biological interactions of graphene-family nanomaterials: an interdisciplinary review. Chem. Res. Toxicol. 2012, 25:15-34.
74. Suarez-Martinez I., Grobert N., Ewels C.P. Nomenclature of sp2 carbon nanoforms. Carbon 2012, 50:741-747.
75. Murr L.E., Soto K.F. A TEM study of soot, carbon nanotubes, and related fullerene nanopolyhedra in common fuel-gas combustion sources. Mater. Charact. 2005, 55:50-65.
76. Kroto H.W., Heath J.R., O'Brien S.C., Curl R.F., Smalley R.E. C60: buckminsterfullerene. Nature 1985, 318:162-163.
77. Monthioux M., Kuznetsov V.L. Who should be given the credit for the discovery of carbon nanotubes?. Carbon 2006, 44:1621-1623.
78. Iijima S. Helical microtubules of graphitic carbon. Nature 1991, 354:56-58.
79. Iijima S., Ichihashi T. Single-shell carbon nanotubes of 1-nm diameter. Nature 1993, 363:603-605.
80. Bethune D.S., Klang C.H., de Vries M.S., Gorman G., Savoy R., Vazquez J., Beyers R. Cobalt-catalysed growth of carbon nanotubes with single-atomic-layer walls. Science 1993, 363:605-607.
81. Novoselov K.S., Geim A.K., Morozov S.V., Jiang D., Zhang Y., Dubonos S.V., Grigorieva I.V., Firsov A.A. Electric field effect in atomically thin carbon films. Science 2004, 306:666-669.
82. Benn T.M., Westerhoff P., Herckes P. Detection of fullerenes (C60 and C70) in commercial cosmetics. Environ. Pollut. 2011, 159:1334-1342.
83. Akkurt F., Kaya N., Alicilar A. Phase transitions, order parameters and threshold voltages in liquid crystal systems doped with disperse orange dye and carbon nanoparticles. Fullerenes Nanotubes Carbon Nanostruct. 2009, 17:616-624.
84. Constantin C., Neagu M., Ion R.-M., Gherghiceanu M., Stavaru C. Fullerene-porphyrin nanostructures in photodynamic therapy. Nanomedicine 2010, 5:307-317.
85. Partha R., Conyers J.L. Biomedical applications of functionalized fullerene-based nanomaterials. Int. J. Nanomed. 2009, 4:261-275.
86. Sinha N., Yeow J. Carbon nanotubes for biomedical applications. IEEE Trans. Nanobiosci. 2005, 4:180-195.
87. Liu Z., Robinson J.T., Tabakman S.M., Yang K., Dai H. Carbon materials for drug delivery and cancer therapy. Mater. Today 2011, 14:316-323.
88. Lu F., Gu L., Meziani M.J., Wang X., Luo P.G., Veca L.M., Cao L., Sun Y.-P. Advances in bioapplications of carbon nanotubes. Adv. Mater. 2009, 21:139-152.
89. Choi B.G., Park H., Park T.J., Yang M.H., Kim J.S., Jang S.Y., Heo N.S., Lee S.Y., Kong J., Hong W.H. Solution chemistry of self-assembled graphene nanohybrids for high-performance flexible biosensors. ACS Nano 2010, 4:2910-2918.
90. Jung J.H., Cheon D.S., Liu F., Lee K.B., Seo T.S. A graphene oxide based immuno-biosensor for pathogen detection. Angew. Chem. Int. Ed. 2010, 49:5708-5711.
91. Zhang L., Xia J., Zhao Q., Liu L., Zhang Z. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. Small 2010, 6:537-544.
92. Liu K., Zhang J., Cheng F., Zheng T., Wang C., Zhu J. Green and facile synthesis of highly biocompatible graphene nanosheets and its application for cellular imaging and drug delivery. J. Mater. Chem. 2011, 21:12034.
93. Muller J., Huaux F., Lison D. Respiratory toxicity of carbon nanotubes: how worried should we be?. Carbon 2006, 44:1048-1056.
94. Lam C., James J.T., McCluskey R., Arepalli S., Hunter R.L. A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit. Rev. Toxicol. 2006, 36:189-217.
95. Zhao X., Liu R. Recent progress and perspectives on the toxicity of carbon nanotubes at organism, organ, cell, and biomacromolecule levels. Environ. Int. 2012, 40:244-256.
96. Morimoto Y., Kobayashi N., Shinohara N., Myojo T., Tanaka I., Nakanishi J. Hazard assessments of manufactured nanomaterials. J. Occup. Health 2010, 52:325-334.
97. Hoet P.H.M., Brüske-Hohlfeld I., Salata O.V. J. Nanobiotechnol. 2004, 2:12.
98. Kayat J., Gajbhiye V., Tekade R.K., Jain N.K. Pulmonary toxicity of carbon nanotubes: a systematic report. Nanomed. Nanotechnol. Biol. Med. 2011, 7:40-49.
99. Aoshima H., Saitoh Y., Ito S., Yamana S., Miwa N. Safety evaluation of highly purified fullerenes (HPFs): based on screening of eye and skin damage. J. Toxicol. Sci. 2009, 34:555-562.
100. Ema M., Matsuda A., Kobayashi N., Nayo M., Nakanishi J. Evaluation of dermal and eye irritation and skin sensitization due to carbon nanotubes. Regul. Toxicol. Pharm. 2011, 61:276-281.
101. Miyawaki J., Yudasaka M., Azami T., Kudo Y., Iijima S. Toxicity of single-carbon nanohorns. ACS Nano 2008, 2:213-226.
102. Murphy F.A., Poland C.A., Duffin R., Al-Jamal K.T., Ali-Boucetta H., Nunes A., Byrne F., Prina-Mello A., Volkov Y., Li S., Mather S.J., Bianco A., Prato M., MacNee W., Wallace W.A., Kostarelos K., Donaldson K. Length-dependent retention of carbon nanotubes in the pleural space of mice initiates sustained inflammation and progressive fibrosis on the parietal pleura. Am. J. Pathol. 2011, 178:2587-2600.
103. Lindberg H.K., Falck G.C.M., Suhonen S., Vippola M., Vanhala E., Catalán J., Savolainen K., Norppa H. Genotoxicity of nanomaterials: DNA damage and micronuclei induced by carbon nanotubes and graphite nanofibres in human bronchial epithelial cells in vitro. Toxicol. Lett. 2009, 186:166-173.
104. Wörle-Knirsch J.M., Krug H.F. Cause I'm CNT, not dynamite. Nano Today 2006, 1:48.
105. Zhang Y., Ali S.F., Dervishi E., Xu Y., Li Z., Casciano D., Biris A.S. Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells. ACS Nano 2010, 4:3181-3186.
106. Mutlu G.M., Budinger G.R., Green A.A., Urich D., Soberanes S., Chiarella S.E., Alheid G.F., McCrimmon D.R., Szleifer I., Hersam M.C. Biocompatible nanoscale dispersion of single-walled carbon nanotubes minimizes in vivo pulmonary toxicity. Nano Lett. 2010, 10:1664-1670.
107. Duch M.C., Budinger G.R., Liang Y.T., Soberanes S., Urich D., Chiarella S.E., Campochiaro L.A., Gonzalez A., Chandel N.S., Hersam M.C., Mutlu G.M. Minimizing oxidation and stable nanoscale dispersion improves the biocompatibility of graphene in the lung. Nano Lett. 2011, 11:5201-5207.
108. Wang K., Ruan J., Song H., Zhang J., Wo Y., Guo S., Cui D. Biocompatibility of graphene oxide. Nanoscale Res. Lett. 2011, 6:8.
109. Cheng Y., Yang S.T., Liu J.H., Dong E., Wang Y., Cao A., Liu Y., Wang H. In vitro toxicity evaluation of graphene oxide on A549 cells. Toxicol. Lett. 2011, 200:201-210.
110. Oh W.K., Kim S., Yoon H., Jang J. Shape-dependent cytotoxicity and proinflammatory response of poly(3,4-ethylenedioxythiophene) nanomaterials. Small 2010, 6:872-879.
111. Simon-Deckers A., Loo S., Mayne-L'hermite M., Herlin-Boime N., Menguy N., Reynaud C., Gouget B., Carrière M. Size-, composition- and shape-dependent toxicological impact of metal oxide nanoparticles and carbon nanotubes toward bacteria. Environ. Sci. Technol. 2009, 43:8423-8429.
112. Yuan J., Gao H., Ching C.B. Comparative protein profile of human hepatoma HepG2 cells treated with graphene and single-walled carbon nanotubes: an iTRAQ-coupled 2D LC-MS/MS proteome analysis. Toxicol. Lett. 2011, 207:213-221.
113. Schinwald A., Murphy F.A., Jones A., MacNee W., Donaldson K. Graphene-based nanoplatelets: a new risk to the respiratory system as a consequence of their unusual aerodynamic properties. ACS Nano 2012, 6:736-746.
114. Song M., Yuan S., Yin J., Wang X., Meng Z., Wang H., Jiang G. Size-dependent toxicity of nano-C60 aggregates: more sensitive indication by apoptosis-related Bax translocation in cultured human cells. Environ. Sci. Technol. 2012, 46:3457-3464.
115. Asharani P.V., Lian Wu Y., Gong Z., Valiyaveettil S. Toxicity of silver nanoparticles in zebrafish models. Nanotechnology 2008, 19:255102.
116. Asharani P.V., Lian Wu Y., Gong Z., Valiyaveettil S. Comparison of the toxicity of silver, gold and platinum nanoparticles in developing zebrafish embryos. Nanotoxicology 2011, 5:43-54.
117. Bai W., Zhang Z.Y., Tian W.J., He X., Ma Y.H., Zhao Y.L., Chai Z.F. Toxicity of zinc oxide nanoparticles to zebrafish embryo: a physicochemical study of toxicity mechanism. J. Nanopart. Res. 2010, 12:1645-1654.
118. Chen H.-W., Su S.-F., Chien C.-T., Lin W.-H., Yu S.-L., Chou C.-C., Chen J.J.W., Yang P.-C. Titanium dioxide nanoparticles induce emphysema-like lung injury in mice. FASEB 2006, 20:2393-2395.
119. Cho W.S., Cho M.J., Jeong J., Choi M., Cho H.Y., Han B.S., Kim S.H., Kim H.O., Lim Y.T., Chung B.H., Jeong J. Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. Toxicol. Appl. Pharmacol. 2009, 236:16-24.
120. Duffin R., Tran L., Brown D., Stone V., Donaldson K. Proinflammogenic effects of low-toxicity and metal nanoparticles in vivo and in vitro: highlighting the role of particle surface area and surface reactivity. Inhalation Toxicol. 2007, 19:849-856.
121. Federici G., Shaw B.J., Handy R.D. Toxicity of titanium dioxide nanoparticles to rainbow trout (Oncorhynchus mykiss): gill injury, oxidative stress, and other physiological effects. Aquat. Toxicol. 2007, 84:415-430.
122. Franklin N.M., Rogers N.J., Apte S.C., Batley G.E., Gadd G.E., Casey P.S. Comparative toxicity of nanoparticulate ZnO, bulk ZnO, and ZnCl2 to a freshwater microalga (Pseudokirchneriella subcapitata): the importance of particle solubility. Environ. Sci. Technol. 2007, 41:8484-8490.
123. Goodman C.M., McCusker C.D., Yilmaz T., Rotello V.M. Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. Bioconjug. Chem. 2004, 15:897-900.
124. Hussain S.M., Hess K.L., Gearhart J.M., Geiss K.T., Schlager J.J. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol. in Vitro 2005, 19:975-983.
125. Kasemets K., Ivask A., Dubourguier H.C., Kahru A. Toxicity of nanoparticles of ZnO, CuO and TiO2 to yeast Saccharomyces cerevisiae. Toxicol. in Vitro 2009, 23:1116-1122.
126. Li M., Zhu L.Z., Lin D.H. Toxicity of ZnO nanoparticles to Escherichia coli: mechanism and the influence of medium components. Environ. Sci. Technol. 2011, 45:1977-1983.
127. Li T., Albee B., Alemayehu M., Diaz R., Ingham L., Kamal S., Rodriguez M., Bishnoi S.W. Comparative toxicity study of Ag, Au, and Ag-Au bimetallic nanoparticles on Daphnia magna. Anal. Bioanal. Chem. 2010, 398:689-700.
128. Mortimer M., Kasemets K., Kahru A. Toxicity of ZnO and CuO nanoparticles to ciliated protozoa Tetrahymena thermophila. Toxicology 2010, 269:182-189.
129. Wu J., Liu W., Xue C., Zhou S., Lan F., Bi L., Xu H., Yang X., Zeng F.D. Toxicity and penetration of TiO2 nanoparticles in hairless mice and porcine skin after subchronic dermal exposure. Toxicol. Lett. 2009, 191:1-8.
130. Yang X.Y., Edelmann R.E., Oris J.T. Suspended C(60) nanoparticles protect against short-term UV and fluoranthene photo-induced toxicity, but cause long-term cellular damage in Daphnia magna. Aquat. Toxicol. 2010, 100:202-210.
131. Zhang Y., Chen W., Zhang J., Liu J., Chen G., Pope C. In vitro and in vivo toxicity of CdTe nanoparticles. J. Nanosci. Nanotechnol. 2007, 7:497-503.
132. Braydich-Stolle L.K., Schaeublin N.M., Murdock R.C., Jiang J., Biswas P., Schlager J.J., Hussain S.M. Crystal structure mediates mode of cell death in TiO2 nanotoxicity. J. Nanopart. Res. 2009, 11:1361-1374.
133. Braydich-Stolle L., Hussain S., Schlager J.J., Hofmann M.-C. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol. Sci. 2005, 88:412-419.
134. Moss O.R., Wong V.A. When nanoparticles get in the way: impact of projected area on in vivo and in vitro macrophage function. Inhalation Toxicol. 2006, 18:711-716.
135. Oberdörster G. Nanotoxicology: in vitro-in vivo dosimetry. Environ. Health Perspect. 2012, 120:A13.
136. Torrens F. Calculations on solvents and co-solvents of single-wall carbon nanotubes: cyclopyranoses. Nanotechnology 2005, 16:S181-S189.
137. Cedervall T., Lynch I., Lindman S., Berggård T., Thulin E., Nilsson H., Dawson K.A., Linse S. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. PNAS 2007, 104:2050-2055.
138. Kim J.S., Yoon T.J., Kim B.G., Park S.J., Kim H.W., Lee K.H., Park S.B., Lee J.K., Cho M.H. Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol. Sci. 2006, 89:338-347.
139. Horie M., Kato H., Fujita K., Endoh S., Iwahashi H. In vitro evaluation of cellular response induced by manufactured nanoparticles. Chem. Res. Toxicol. 2012, 25(3):605-619.
140. Karlsson H.L., Cronholm P., Gustafsson J., Möller L. Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem. Res. Toxicol. 2008, 21:1726-1732.
141. Fahmy B., Cormier S.A. Copper oxide nanoparticles induce oxidative stress and cytotoxicity in airway epithelial cells. Toxicol. in Vitro 2009, 23:1365-1371.
142. Horie M., Nishio K., Fujita K., Kato H., Endoh S., Suzuki M., Nakamura A., Miyauchi A., Kinugasa S., Yamamoto K., Iwahashi H., Murayama H., Niki E., Yoshida Y. Cellular responses by stable and uniform ultrafine titanium dioxide particles in culture-medium dispersions when secondary particle size was 100 nm or less. Toxicol. in Vitro 2010, 24:1629-1638.
143. Fujita K., Horie M., Kato H., Endoh S., Suzuki M., Nakamura A., Miyauchi A., Yamamoto K., Kinugasa S., Nishio K., Yoshida Y., Iwahashi H., Nakanishi J. Effects of ultrafine TiO2 particles on gene expression profile in human keratinocytes without illumination: involvement of extracellular matrix and cell adhesion. Toxicol. Lett. 2009, 191:109-117.
144. Puzyn T., Rasulev B., Gajewicz A., Hu X., Dasari T.P., Michalkova A., Hwang H.-M., Toropov A., Leszczynska D., Leszczynski J. Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles. Nat. Nanotechnol. 2011, 6:175-178.
145. Wang J., Lu Z., Gao Y., Wientjes M.G., Au J.L.-U. Improving delivery and efficacy of nanomedicines in solid tumors. Nanomedicine 2011, 6:1605-1620.
146. Peters K., Unger R.E., Kirkpatrick C.J., Gatti A.M., Monari E. Effects of nano-scaled particles on endothelial cell function in vitro: studies on viability, proliferation and inflammation. J. Mater. Sci. Mater. Med. 2004, 15:321-325.
147. Linkov I., Satterstrom F.K., Corey L.M. Nanotoxicology and nanomedicine: making hard decisions. Nanomed. Nanotechnol. Biol. Med. 2008, 4:167-171.
148. Russell W.M.S., Burch R.L. The Principles of Humane Experimental Technique 1959, Methuen, London, UK.
149. Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. Official Journal of the European Union, L 396/1 of 30.12.2006. Office for Official Publications of the European Communities (OPOCE) 2006, E. Commission (Ed.).
150. van der Jagt K., Munn S., Tørsløv J., de Bruijn J. Alternative approaches can reduce the use of test animals under REACH. JRC Report EUR 21405 2004.
151. Schultz T.W., Cronin M.T.D., Walker J.D., Aptula A.O. Quantitative structure-activity relationships (QSARs) in toxicology: a historical perspective. J. Mol. Struct. (THEOCHEM) 2003, 622:1-22.
152. Leszczynski J. BIONANOSCIENCE nano meets bio at the interface. Nat. Nanotechnol. 2010, 5:633-634.
153. Barnard A.S. How can ab initio simulations address risks in nanotech?. Nat. Nanotechnol. 2009, 4:332-335.
154. Lacerda L., Bianco A., Prato M., Kostarelos K. Carbon nanotubes as nanomedicines: from toxicology to pharmacology. Adv. Drug Deliv. Rev. 2006, 58:1460.
155. Zuo G., Zhou X., Huang Q., Fang H., Zhou R. Adsorption of villin headpiece onto graphene, carbon nanotube, and C60: effect of contacting surface curvatures on binding affinity. J. Phys. Chem. C 2011, 115:23323-23328.
156. Sun W., Bu Y. On the binding strength sequence for nucleic acid bases and C60 with density functional and dispersion-corrected density functional theories: whether C60 could protect nucleic acid bases from radiation-induced damage. J. Phys. Chem. C 2011, 3220-3228.
157. Durdagi S., Mavromoustakos T., Papadopulos M.G. 3D QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies of fullerene-based HIV-1 PR inhibitors. Bioorg. Med. Chem. Lett. 2008, 18:6283-6289.
158. Durdagi S., Mavromoustakos T., Chronakis N., Papadopoulos M.G. Computational design of novel fullerene analogs as potential HIV 1 PR inhibitors: analysis of the binding interactions between fullerene Inhibitors and HIV 1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations. Bioorg. Med. Chem. Lett. 2008, 16:9957-9974.
159. Martin D., Karelson M. The quantitative structure activity relationships for predicting HIV protease inhibition by substituted fullerenes. Lett. Drug Des. Discovery 2010, 7:587-595.
160. Kraszewski S., Tarek M., Treptow W., Ramseyer C. Affinity of C60 neat fullerenes with membrane proteins: a computational study on potassium channels. ACS Nano 2010, 4:4158-4164.
161. Yang S.-T., Wang H., Guo L., Gao Y., Liu Y., Cao A. Interaction of fullerenol with lysozyme investigated by experimental and computational approaches. Nanotechnology 2008, 19:395101.
162. Bianco A., Kostarelos K., Prato M. Making carbon nanotubes biocompatible and biodegradable. Chem. Commun. 2011, 47:10182-10188.
163. Mananghaya M., Rodulfo E., Santos G.N., Villagracia A.R. Theoretical investigation on the solubilization in water of functionalized single-wall carbon nanotubes. J. Nanotechnol. 2012, 2012:780815.
164. Sayes C.M., Liang F., Hudson J.L., Mendez J., Guo W., Beach J.M., Moore V.C., Doyle C.D., West J.L., Billups W.E., Ausman K.D., Colvin V.L. Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro. Toxicol. Lett. 2006, 161:135-142.
165. Sasidharan A., Panchakarla L.S., Chandran P., Menon D., Nair S., Rao C.N.R., Koyakutty M. Differential nano-bio interactions and toxicity effects of pristine versus functionalized graphene. Nanoscale 2011, 3:2461.
166. Obata S., Honda K. Dynamic behavior of carbon nanotube and bio-/artificial surfactants complexes in an aqueous environment. J. Phys. Chem. C 2011, 115:19659-19667.
167. Gao H., Kong Y., Cui D., Ozkan C.Z. Spontaneous insertion of DNA oligonucleotides into carbon nanotubes. Nano Lett. 2003, 3:471-473.
168. Monajjemi M., Mollaamin F. Molecular modeling study of drug-DNA combined to single walled carbon nanotube. J. Clust. Sci. 2012, 23:259-272.
169. Makarucha A.J., Todorova N., Yarovsky I. Nanomaterials in biological environment: a review of computer modelling studies. Eur. Biophys. J. 2011, 40:103-115.
170. Johnson R.R., Kohlmeyer A., Johnson A.T.C., Klein M.L. Free energy landscape of a DNA-carbon nanotube hybrid using replica exchange molecular dynamics. Nano Lett. 2009, 9:537-541.
171. Titov A.V., Kral P., Pearson R. Sandwiched graphene-membrane superstructures. ACS Nano 2010, 4:229-234.
172. Çaǧin T., Che J., Qi Y., Zhou Y., Demiralp E., Gao G., Goddard III W.A. Computational materials chemistry at the nanoscale. J. Nanopart. Res. 1999, 1:51-69.
173. Puzyn T., Leszczynska D., Leszczynski J. Toward the development of "Nano-QSARs": advances and challenges. Small 2009, 5:2494-2509.
174. Aruoja V., Dubourguier H.C., Kasemets K., Kahru A. Toxicity of nanoparticles of CuO, ZnO and TiO2 to microalgae Pseudokirchneriella subcapitata. Sci. Total. Environ. 2009, 407:1461-1468.
175. Heinlaan M., Ivask A., Blinova I., Dubourguier H.C., Kahru A. Toxicity of nanosized and bulk ZnO, CuO and TiO2 to bacteria Vibrio fischeri and crustaceans Daphnia magna and Thamnocephalus platyurus. Chemosphere 2008, 71:1308-1316.
176. Blinova I., Ivask A., Heinlaan M., Mortimer M., Kahru A. Ecotoxicity of nanoparticles of CuO and ZnO in natural water. Environ. Pollut. 2010, 158:41-47.
177. Cook S.M., Aker W.G., Rasulev B.F., Hwang H.M., Leszczynski J., Jenkins J.J., Shockley V. Choosing safe dispersing media for C60 fullerenes by using cytotoxicity tests on the bacterium Escherichia coli. J. Hazard. Mater. 2010, 176:367-373.
178. Navarro E., Piccapietra F., Wagner B., Marconi F., Kaegi R., Odzak N., Sigg L., Behra R. Toxicity of silver nanoparticles to Chlamydomonas reinhardtii. Environ. Sci. Technol. 2008, 42:8959-8964.
179. Reddy K.M., Feris K., Bell J., Wingett D.G., Hanley C., Punnoose A. Selective toxicity of zinc oxide nanoparticles to prokaryotic and eukaryotic systems. Appl. Phys. Lett. 2007, 90.
180. Rispoli F., Angelov A., Badia D., Kumar A., Seal S., Shah V. Understanding the toxicity of aggregated zero valent copper nanoparticles against Escherichia coli. J. Hazard. Mater. 2010, 180:212-216.
181. Posgai R., Cipolla-McCulloch C.B., Murphy K.R., Hussain S.M., Rowe J.J., Nielsen M.G. Differential toxicity of silver and titanium dioxide nanoparticles on Drosophila melanogaster development, reproductive effort, and viability: size, coatings and antioxidants matter. Chemosphere 2011, 85:34-42.
182. Schaeublin N.M., Braydich-Stolle L.K., Maurer E.I., Park K., MacCuspie R.I., Afrooz A.R.M.N., Vaia R.A., Saleh N.B., Hussain S.M. Does shape matter? Bioeffects of gold nanomaterials in a human skin cell model. Langmuir 2012, 28:3248-3258.
183. Schaeublin N.M., Braydich-Stolle L.K., Schrand A.M., Miller J.M., Hutchison J., Schlager J.J., Hussain S.M. Surface charge of gold nanoparticles mediates mechanism of toxicity. Nanoscale 2011, 3:410-420.
184. Toropov A.A., Benfenati E. SMILES in QSPR/QSAR Modeling: results and perspectives. Curr. Drug Discov. Technol. 2007, 4:77-116.
185. Bonnefoi M.S., Belanger S.E., Devlin D.J., Doerrer N.G., Embry M.R., Fukushima S., Harpur E.S., Hines R.N., Holsapple M.P., Kim J.H., MacDonald J.S., O'Lone R., Pettit S.D., Stevens J.L., Takei A.S., Tinkle S.S., Van Der Laan J.W. Human and environmental health challenges for the next decade (2010-2020). Crit. Rev. Toxicol. 2010, 40:893-911.
186. Moore M.N. Do nanoparticles present ecotoxicological risks for the health of the aquatic environment?. Environ. Int. 2006, 32:967-976.
187. Tsuji J.S., Maynard A.D., Howard P.C., James J.T., Lam C.-W., Warheit D.B., Santamaria A.B. Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles. Toxicol. Sci. 2006, 89:42-50.
188. Nel A.E., Mädler L., Velegol D., Xia T., Hoek E.M.V., Somasundaran P., Klaessig F., Castranova V., Thompson M. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 2009, 8:543-557.
189. Rivera Gil P., Oberdörster G., Elder A., Puntes V., Parak W.J. Correlating physico-chemical with toxicological properties of nanoparticles: the present and the future. ACS Nano 2010, 4:5527-5531.
190. Xia T., Kovochich M., Liong M., Madler L., Gilbert B., Shi H.B., Yeh J.I., Zink J.I., Nel A.E. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2008, 2:2121-2134.
191. Topliss J.G., Costello R.J. Chance correlations in structure-activity studies using multiple regression analysis. J. Med. Chem. 1972, 15:1066-1068.
192. Ben-Moshe T., Dror I., Berkowitz B. Transport of metal oxide nanoparticles in saturated porous media. Chemosphere 2010, 81:387-393.
193. Chen Z., Meng H.A., Xing G.M., Chen C.Y., Zhao Y.L., Jia G.A., Wang T.C., Yuan H., Ye C., Zhao F., Chai Z.F., Zhu C.F., Fang X.H., Ma B.C., Wan L.J. Acute toxicological effects of copper nanoparticles in vivo. Toxicol. Lett. 2006, 163:109-120.
194. Han X., Gelein R., Corson N., Wade-Mercer P., Jiang J., Biswas P., Finkelstein J.N., Elder A., Oberdörster G. Validation of an LDH assay for assessing nanoparticle toxicity. Toxicology 2011, 287:99-104.
195. Ivask A., Bondarenko O., Jepihhina N., Kahru A. Profiling of the reactive oxygen species-related ecotoxicity of CuO, ZnO, TiO(2), silver and fullerene nanoparticles using a set of recombinant luminescent Escherichia coli strains: differentiating the impact of particles and solubilised metals. Anal. Bioanal. Chem. 2010, 398:701-716.
196. Hu X.K., Cook S., Wang P., Hwang H.M. In vitro evaluation of cytotoxicity of engineered metal oxide nanoparticles. Sci. Total. Environ. 2009, 407:3070-3072.
197. Ispas C., Andreescu D., Patel A., Goia D.V., Andreescu S., Wallace K.N. Toxicity and developmental defects of different sizes and shape nickel nanoparticles in zebrafish. Environ. Sci. Technol. 2009, 43:6349-6356.
198. Jeong S.W., Kim S.D. Aggregation and transport of copper oxide nanoparticles in porous media. J. Environ. Monit. 2009, 11:1595-1600.
199. Limbach L.K., Li Y.C., Grass R.N., Brunner T.J., Hintermann M.A., Muller M., Gunther D., Stark W.J. Oxide nanoparticle uptake in human lung fibroblasts: effects of particle size, agglomeration, and diffusion at low concentrations. Environ. Sci. Technol. 2005, 39:9370-9376.
200. Murdock R.C., Braydich-Stolle L., Schrand A.M., Schlager J.J., Hussain S.M. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol. Sci. 2008, 101:239-253.
201. Navarro E., Baun A., Behra R., Hartmann N.B., Filser J., Miao A.J., Quigg A., Santschi P.H., Sigg L. Environmental behavior and ecotoxicity of engineered nanoparticles to algae, plants, and fungi. Ecotoxicology 2008, 17:372-386.
202. Skaltsas T., Avgouropoulos G., Tasis D. Impact of the fabrication method on the physicochemical properties of carbon nanotube-based aerogels. Microporous Mesoporous Mater. 2011, 143:451-457.
203. Troshin P.A., Hoppe H., Renz J., Egginger M., Mayorova J.Y., Goryachev A.E., Peregudov A.S., Lyubovskaya R.N., Gobsch G., Sariciftci N.S., Razumov V.F. Material solubility-photovoltaic performance relationship in the design of novel fullerene derivatives for bulk heterojunction solar cells. Adv. Funct. Mater. 2009, 19:779-788.
204. Wang Z.Y., Zhao J., Song L., Mashayekhi H., Chefetz B., Xing B.S. Adsorption and desorption of phenanthrene on carbon nanotubes in simulated gastrointestinal fluids. Environ. Sci. Technol. 2011, 45:6018-6024.
205. Zhu S.Q., Oberdörster E., Haasch M.L. Toxicity of an engineered nanoparticle (fullerene, C-60) in two aquatic species, Daphnia and fathead minnow. Mar. Environ. Res. 2006, 62:S5-S9.
206. Zhu X.S., Zhu L., Chen Y.S., Tian S.Y. Acute toxicities of six manufactured nanomaterial suspensions to Daphnia magna. J. Nanopart. Res. 2009, 11:67-75.
207. Klimish H.-J., Andreae M., Tillmann U. A systematic approach for evaluating the quality of experimental toxicological and ecotoxicological data. Regul. Toxicol. Pharm. 1996, 25:1-5.
208. Jiang J., Oberdörster G., Biswas P. Characterization of size, surface charge, and agglomeration state of nanoparticle dispersions for toxicological studies. J. Nanopart. Res. 2009, 11:77-89.
209. Pitkethly M.J. Nanomaterials - the driving force. Mater. Today 2004, 7:20-29.
210. Powers K.W., Palazuelos M., Moudgil B.M., Roberts S.M. Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studies. Nanotoxicology 2007, 1:42-51.
211. Choi O., Hu Z. Size dependent and reactive oxygen species related nanosilver toxicity to nitrifying bacteria. Environ. Sci. Technol. 2008, 42:4583-4588.
212. Lubick N. Nanosilver toxicity: ions, nanoparticles - or both?. Environ. Sci. Technol. 2008, 42:8617.
213. Schrand A.M., Rahman M.F., Hussain S.M., Schlager J.J., Smith D.A., Syed A.F. Metal-based nanoparticles and their toxicity assessment. WIREs. Nanomed. Nanobiotechnol. 2010, 2:544-568.
214. Ormsby J.L., King B.T. Clar valence bond representation of pi-bonding in carbon nanotubes. J. Org. Chem. 2004, 69:4287-4291.
215. Toropov A.A., Leszczynska D., Leszczynski J. Predicting thermal conductivity of nanomaterials by correlation weighting technological attributes codes. Mater. Lett. 2007, 61:4777-4780.
216. Abraham M.H., Green C.E., Acree W.E. Correlation and prediction of the solubility of Buckminsterfullerene in organic solvents; estimation of some physicochemical properties. Perkin 2000, 2:281-286.
217. Edelstein A.S., Cammarata R.C. Nanomaterials: Synthesis, Properties and Applications 1998, CRC Press.
218. Flunt R., Makitra R., Makohon O., Pyrih J. Quantitative treatment of fullerene C60 solubility data. Org. React. (Tartu) 1997, 31:21-26.
219. Fubini B., Ghiazza M., Fenoglio I. Physico-chemical features of engineered nanoparticles relevant to their toxicity. Nanotoxicology 2010, 4:347-363.
220. Makitra R.G., Pristanskii R.E., Flyunt R.I. Solvent effects on the solubility of C60 fullerene. Russ. J. Gen. Chem 2003, 73:1227-1232. (Translation of Zhurnal Obshchei Khimii).
221. Medina C., Santos-Martinez M.J., Radomski A., Corrigan O.I., Radomski M.W. Nanoparticles: pharmacological and toxicological significance. Br. J. Pharmacol. 2007, 150:552-558.
222. Jensen F. Introduction to Computational Chemistry 1999, Wiley, Chichester, UK.
223. Todeschini R., Consonni V. Handbook of Molecular Descriptors 2000, Wiley-VCH, Weinheim.
224. Mauri A., Consonni V., Pavan M., Todeschini R. DRAGON software: an easy approach to molecular descriptors calculations. Match 2006, 56:237-248.
225. Katritzky A.R., Karelson M., Petrukhin R. CODESSA PRO: Comprehensive Descriptors for Structural and Statistical Analysis 2005, University of Florida, USA, http://www.codessa-pro.com.
226. Katritzky A.R., Petrukhin R., Tatham D., Basak S.C., Benfenati E., Karelson M., Maran U. The interpretation of quantitative structure-property and -activity relationships. J. Chem. Inf. Comput. Sci. 2001, 41:679-685.
227. Cache 5.0. Computer-Aided Chemistry Modeling Software on Windows 2006, Fujitsu, can be found under http://www.cachesoftware.com.
228. Puzyn T., Rostkowski P., Swieczkowski A., Jedrusiak A., Falandysz J. Chemosphere 2006, 62:1817-1828.
229. Frisch M.J., Trucks G.W., Schlegel H.B., Scuseria G.E., Robb M.A., Cheeseman J.R., Revision C. Gaussian 03 2004, Gaussian Inc, Wallingford.
230. Stewart J.J.P., MOPAC2009 Stewart Computational Chemistry http://OpenMOPAC.net.
231. Schmidt M.W., Baldridge K.K., Boatz J.A., Elbert S.T., Gordon M.S., Jensen J.H., Koseki S., Matsunaga N., Nguyen K.A., Su S.J., Windus T.L., Dupuis M., Montgomery J.A. General atomic and molecular electronic structure system. J. Comput. Chem. 1993, 14:1347-1363.
232. Gordon M.S., Schmidt M.W. Theory and Applications of Computational Chemistry: The First Forty Years 2005, 1167-1189. Elsevier, Amsterdam. C.E. Dykstra, G. Frenking, K.S. Kim, G.E. Scuserua (Eds.).
233. Bylaska E.J., de Jong W.A., Kowalski K., Straatsma T.P., Valiev M., Wang D., Apra E., Windus T.L., Hirata S., Hackler M.T.T., Zhao Y., Fan P.-D., Harrison R.J., Dupuis M., Smith D.M.A., Nieplocha J., Tipparaju V., Krishnan M., Auer A.A., Nooijen M., Brown E., Cisneros G., Fann G.I., Frur̈chtl H., Garza J., Hirao K., Kendall R., Nichols J.A., Tsemekhman K., Wolinski K., Anchell J., Bernholdt D., Borowski P., Clark T., Clerc D., Dachsel H., Deegan M., Dyall K., Elwood D., Glendening E., Gutowski M., Hess A., Jaffe J., Johnson B., Ju J., Kobayashi R., Kutteh R., Lin Z., Littlefield R., Long X., Meng B., Nakajima T., Niu S., Pollack L., Rosing M., Sandrone G., Stave M., Taylor H., Thomas G., van Lenthe J., Wong A., Zhang Z. NWChem, a Computational Chemistry Package for Parallel Computers, Ver. 5.0 2006, Pacific Northwest National Laboratory, can be found underhttp://www.emsl.pnl.gov/docs/nwchem/nwchem.html.
234. Jaguar, Version 7.8 2011, Schrödinger, LLC, New York, NY.
235. ADF2012 SCM, Theoretical Chemistry, Vrije Universiteit, Amsterdam, The Netherlands http://www.scm.com.
236. Oprea T.I., Waller C.L., Marshall G.R. Drug Des. Discov. 1994, 12:29-51.
237. Kuzmin V.E., Artemenko A.G., Polischuk P.G., Muratov E.N., Hromov A.I., Liahovskiy A.V., Andronati S.A., Makan S.Y. J. Mol. Model. 2005, 11:457-467.
238. Poggi M.A., Gadsby E.D., Bottomley L.A., King W.P., Oroudjev E., Hansma H. Anal. Chem. 2004, 76:3429-3443.
239. Glotzer S.C., Solomon M.J. Anisotropy of building blocks and their assembly into complex structures. Nat. Mater. 2007, 6:557-562.
240. Xia X.-R., Monteiro-Riviere N.A., Riviere J.E. An index for characterization of nanomaterials in biological systems. Nat. Nanotechnol. 2010, 5:671-675.
241. Lundqvist M. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:14265-14270.
242. Aillon K.L., Xie Y., El-Gendy N., Berkland C.J., Forrest M.L. Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv. Drug Deliv. Rev. 2009, 61:457-466.
243. Xia X.R., Monteiro-Riviere N.A., Mathur S., Song X., Xiao L., Oldenberg S.J., Fadeel B., Riviere J.E. Mapping the surface adsorption forces of nanomaterials in biological systems. ACS Nano 2011, 5:9074-9081.
244. Toropov A.A., Toropova A.P. Prediction of heteroaromatic amine mutagenicity by means of correlation weighting of atomic orbital graphs of local invariants. J. Mol. Struct. (THEOCHEM) 2001, 538:287-293.
245. Toropov A.A., Gutman I., Furtula B. Graph of atomic orbitals and the molecular structure-descriptors based on it. J. Serb. Chem. Soc. 2005, 70:669-674.
246. Toropov A.A., Rasulev B.F., Puzyn T., Leszczynska D., Leszczynski J. Using the graph of atomic orbitals for QSAR modeling of metal oxides toxicity. Fourth International Symposium on Recent Advances in Environmental Health Research, Jackson, MS USA 2007, PB-40.
247. Rasulev B., Toropov A., Puzyn T., Leszczynska D., Leszczynski J. An application of graphs of atomic orbitals for QSAR modeling of toxicity of metal oxides. Federation of Analytical Chemistry and Spectroscopy Symposium (FACSS) 2007.
248. Toropov A.A., Toropova A.P., Benfenati E., Gini G. CORAL SEA software http://www.insilico.eu/CORAL.
249. Mohammaadpour E., Awang M., Abdullah M.Z. Predicting the Young's modulus of single-walled carbon nanotubes using finite element modeling. J. Appl. Sci. 2011, 11:1653-1657.
250. Gajewicz A., Puzyn T., Rasulev B., Leszczynska D., Leszczynski J. Metal oxide nanoparticles: size-dependence of quantum-mechanical properties. Nanosci. Nanotechnol.-Asia 2011, 1:53-58.
251. Qu Z.W., Kroes G.J. Theoretical study of the electronic structure and stability of titanium dioxide clusters (TiO2)n with n = 1-9. J. Phys. Chem. B 2006, 110:8998-9007.
252. Wang J.L., Mezey P.G. The electronic structures and properties of open-ended and capped carbon nano-needles. J. Chem. Inf. Model. 2006, 46:801-807.
253. Poater A., Saliner A.G., Worth A. 2nd Nanotoxicology Conference, Venice, Italy 2007.
254. The appropriateness of existing methodologies to assess the potential risks associated with engineered and adventitious products of nanotechnologies. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) 2006, European Commission, 2006.
255. ChemAxon http://www.chemaxon.com.
256. PK Solutions http://www.summitpk.com.
257. GastroPLUS http://www.simulations-plus.com.
258. Schrödinger Suite 2012 2012, Schrödinger, LLC, New York, NY.
259. SYBYL 8.0 Tripos International, 1699 South Hanley Rd., St. Louis, Missouri, 63144, USA 2011.
260. Discovery Studio Modeling Environment, Release 3.1, in, Accelrys Software Inc., San Diego: Accelrys Software Inc., 2012.
261. Autodock 4.0 The Scripps Research Institute http://autodock.scripps.edu/.
262. Simeon T.M., Yanov I., Leszczynski J. Ab initio quantum chemical studies of fullerene molecules with substitutes C59X [X[=]Si, Ge, Sn], C59X-[X[=]B, Al, Ga, In], and C59X [X[=]N, P, As, Sb]. Int. J. Quantum Chem. 2005, 105:429-436.
263. Schwarz J.A., Contescu C.I. Surfaces of Nanoparticles and Porous Materials 1999, CRC Press.
264. Hohenberg P., Kohn W., Physical G. Inhomogeneous electron gas. Phys. Rev. 1964, 136:864-871.
265. Danauskas S.M., Jurs P.C. Prediction of C60 solubilities from solvent molecular structures. J. Chem. Inf. Comput. Sci. 2001, 41:419-424.
266. Liu H., Yao X., Zhang R., Liu M., Hu Z., Fan B. Accurate quantitative structure-property relationship model to predict the solubility of C60 in various solvents based on a novel approach using a least-squares support vector machine. J. Phys. Chem. B 2005, 109:20565-20571.
267. Petrova T., Rasulev B.F., Toropov A.A., Leszczynska D., Leszczynski J. Improved model for fullerene C60 solubility in organic solvents based on quantum-chemical and topological descriptors. J. Nanopart. Res. 2011, 13:3235-3247.
268. Smith A.L., Wilson L.Y., Famini G.R. A quantitative structure-property relationship study of C60 solubility. Proc. Electrochem. Soc. 1996, 96-10:53-62.
269. Sivaraman N., Srinivasan T.G., Rao P.R.V., Natarajan R. QSPR modeling for solubility of fullerene (C60) in organic solvents. J. Chem. Inf. Comput. Sci. 2001, 41:1067-1074.
270. Toropov A.A., Leszczynska D., Leszczynski J. QSPR study on solubility of fullerene C60 in organic solvents using optimal descriptors calculated with SMILES. Chem. Phys. Lett. 2007, 441:119-122.
271. Toropov A.A., Rasulev B.F., Leszczynska D., Leszczynski J. Multiplicative SMILES-based optimal descriptors: QSPR modeling of fullerene C60 solubility in organic solvents. Chem. Phys. Lett. 2008, 457:332-336.
272. Toropov A.A., Toropova A.P., Benfenati E., Leszczynska D., Leszczynski J. Additive InChI-based optimal descriptors: QSPR modeling of fullerene C 60 solubility in organic solvents. J. Math. Chem. 2009, 46:1232-1251.
273. Abraham M.H., Du C.M., Grate J.W., McGill R.A., Shuely W.J. Fullerene as an adsorbent for gases and vapours. J. Chem. Soc. Chem. Commun. 1993, 1863-1864.
274. Quina F.H., Alonso E.O., Farah J.P.S. Incorporation of nonionic solutes into aqueous micelles: a linear solvation free energy relationship analysis. J. Phys. Chem. 1995, 99:11708-11714.
275. Zhao Y.H., Le J., Abraham M.H., Hersey A., Eddershaw P.J., Luscombe C.N., Boutina D., Beck G., Sherborne B., Cooper I., Platts J.A. Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors. J. Pharm. Sci. 2001, 90:749-784.
276. Marcus Y., Smith A.L., Korobov M.V., Mirakyan A.L., Avramenko N.V., Stukalin E.B. Solubility of C60 fullerene. J. Phys. Chem. B 2001, 105:2499-2506.
277. Hansen C.H., Smith A.L. Using Hansen solubility parameters to correlate solubility of C60 fullerene in organic solvents and in polymers. Carbon 2004, 42:1591-1597.
278. Huang J.-C. Multiparameter solubility model of fullerene C60. Fluid Phase Equilib. 2005, 237:186-192.
279. Thomas E.R., Newman B.A., Long T.C., Wood D.A., Eckert C.A. Limiting activity coefficients of nonpolar and polar solutes in both volatile and nonvolatile solvents by gas chromatography. J. Chem. Eng. Data 1982, 27:399-405.
280. Toropov A., Leszczynska D., Leszczynski J. Predicting water solubility and octanol water partition coefficient for carbon nanotubes based on the chiral vector. Comput. Biol. Chem. 2007, 31:127-128.
281. Toropov A.A., Rasulev B.F., Leszczynska D., Leszczynski J. New approach to QSPR modeling of fullerene C60 solubility, in organic solvents: an application of SMILES-based optimal descriptors. Medicinal Chemistry and Pharmacological Potential of Fullerenes and Carbon Nanotubes 2008, 337-350. Springer, London, New York. F. Cataldo, T. Da Ros (Eds.).
282. Toropov A.A., Rasulev B.F., Leszczynska D., Leszczynski J. Additive SMILES based optimal descriptors: QSPR modeling of fullerene C60 solubility in organic solvents. Chem. Phys. Lett. 2007, 444:209-214.
283. Toropov A.A., Benfenati E. SMILES as an alternative to the graph in QSAR modelling of bee toxicity. Comput. Biol. Chem. 2007, 31:57-60.
284. Toropov A., Nesmerak K., Raska I., Waisser K., Palat K. QSPR modeling of the half-wave potentials of benzoxazines by optimal descriptors calculated with the SMILES. Comput. Biol. Chem. 2006, 30:434-437.
285. Toropov A.A., Toropova A.P., Mukhamedzhanova D.V., Gutman I., Chemistry A. Simplified molecular input line entry system (SMILES) as an alternative for constructing quantitative structure-property relationships (QSPR). Indian J. Chem., Sect A 2005, 44:1545-1552.
286. Vidal D., Thormann M., Pons M. LINGO, an efficient holographic text based method to calculate biophysical properties and intermolecular similarities. J. Chem. Inf. Model. 2005, 45:386-393.
287. Toropova A.P., Toropov A.A., Benfenati E., Gini G. Simplified molecular input-line entry system and International Chemical Identifier in the QSAR analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors. Chem. Biol. Drug Des. 2011, 77:343-360.
288. InChI, Unofficial http://wwmm.ch.cam.ac.uk/inchifaq.
289. Goodarzi M., Duchowicz P.R., Freitas M.P., Fernández F.M. Prediction of the Hildebrand parameter of various solvents using linear and nonlinear approaches. Fluid Phase Equilib. 2010, 293:130-136.
290. Pourbasheer E., Riahi S., Ganjali M.R., Norouzi P. Prediction of solubility of fullerene C60 in various organic solvents by genetic algorithm-multiple linear regression. Fullerenes Nanotubes Carbon Nanostruct. 2011, 19:585-598.
291. Toropova A.P., Toropov A.A., Benfenati E., Gini G., Leszczynska D., Leszczynski J. CORAL: QSPR models for solubility of [C 60] and [C 70] fullerene derivatives. Mol. Diversity 2011, 15:249-256.
292. Fourches D., Pu D., Tassa C., Weissleder R., Shaw S.Y., Mumper R.J., Tropsha A. Quantitative nanostructure - activity relationship modeling. ACS Nano 2010, 4:5703-5712.
293. Liu J., Hopfinger A.J. Identification of possible sources of nanotoxicity from carbon nanotubes inserted into membrane bilayers using membrane interaction quantitative structure-activity relationship analysis. Chem. Res. Toxicol. 2008, 21:459-466.
294. Toropov A.A., Benfenati E. Correlation weighting of valence shells in QSAR analysis of toxicity. Bioorg. Med. Chem. 2006, 14:3923-3928.
295. Tran C.L., Tantra R., Donaldson K., Stone V., Hankin S.M., Ross B., Aitken R.J., Jones A.D. A hypothetical model for predicting the toxicity of high aspect ratio nanoparticles (HARN). J. Nanopart. Res. 2011, 1-16.
296. Fadeel B., Garcia-Bennett A.E. Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv. Drug Deliv. Rev. 2010, 62:362-374.